Form D · Other Technology
Eden Health, Inc.
New York, NY · CIK 0001721728
Offering snapshot reported Feb 19, 2021 · SEC filing
- Reported sold
- $60M Offering amount: $60M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 5, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 19, 2021 | Initial | $59,999,998 | No comparison | 18 | SEC filing |
| Dec 28, 2018 | Initial | $9,624,993 | No comparison | 15 | SEC filing |
| Nov 27, 2017 | Initial | $3,805,244 | No comparison | 35 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-389966
Source: Form D, filed Feb 19, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dan Gebremedhin | Director |
| Jason Lee | Executive |
| Matthew Johnson Mc Cambridge | Director, Executive |
| Scott Luke Sansovich Jr. | Director, Executive |
| Benjamin Stein | Director |
| John Stoddard | Director |
| Ellie Wheeler | Director |
| Joseph Wiener | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
101 Greenwich Street Suite 403
New York, NY, 10006
New York, NY, 10006